博安生物：山东绿叶制药拟向Luye Geneora Holding进一步转让公司3850万股H股

Group 1 - The company Boan Biotechnology (06955) announced that its board has been informed by its controlling shareholder, Luye Pharma Group, regarding a subscription agreement related to exchangeable preferred shares [1] - Luye Pharma's wholly-owned subsidiary, Shandong Luye Pharmaceutical Co., Ltd., is set to transfer 38.5 million H-shares to the issuer, Luye Geneora Holding Limited, on January 22, 2026, as part of the proposed transfer [1]